ConductScience.org, home

Paper3496540

A new member of the immunoglobulin superfamily--CTLA-4.

Brunet JF and 6 others. Nature, 1987. Cited by 1,036 papers, by iCite.

Cite this record

ConductScience Library. A new member of the immunoglobulin superfamily--CTLA-4. Papers, record 3496540. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3496540

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A new member of the immunoglobulin superfamily--CTLA-4.
PubMed
Journal
Nature
PubMed
Year
1987
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1,036
iCite
Relative citation ratio, by iCite
18.1
iCite
Revised in PubMed
2022-03-30
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brunet JFJ F
2Denizot FF
3Luciani MFM F
4Roux-Dosseto MM
5Suzan MM
6Mattei MGM G
7Golstein PP

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ImmunoglobulinsMajor topic
Multigene FamilyMajor topic
T-LymphocytesMajor topic
Amino Acid Sequence
Animals
Chromosome Mapping
Cloning, Molecular
DNA
Gene Expression Regulation
Mice
RNA, Messenger
Sequence Homology, Nucleic Acid

Source PubMed

Download CSV of topics

Cited by521

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,036 citations.

PMIDTitleJournalYearIn PapersSource
42822444Distant lymph nodes compensate for resected tumor-draining lymph nodes during cancer immunotherapy.Immunity2026https://conductscience.org/library/papers/42822444PubMed
42730022Inhibitory immune checkpoints in preeclampsia: current landscape, mechanisms, and clinical perspectives.Front Immunol2026https://conductscience.org/library/papers/42730022PubMed
42680727Immune checkpoints and immunoregulation in metabolic diseases and cancers: pathological mechanisms and therapeutic potential.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42680727PubMed
42568362Overcoming immunotherapy barriers in pediatric brain tumors: epigenetic strategies.Front Oncol2026https://conductscience.org/library/papers/42568362PubMed
42549409Association between Cytotoxic T-Lymphocyte Antigen - 4 +49A>G Variant and Reduced Risk of Recurrent Spontaneous Abortion in Indian Bengali Population: A Case-Control Study.J Hum Reprod Sci2026https://conductscience.org/library/papers/42549409PubMed
42428346New and emerging strategies for targeting cancers: Challenges and opportunities (Review).Oncol Lett2026https://conductscience.org/library/papers/42428346PubMed
42393377A guide to CAR T cell therapies: development, current status and future prospects.Nat Rev Immunol2026https://conductscience.org/library/papers/42393377PubMed
42327747Mechanisms and biomarkers of immune checkpoint inhibitor-associated myocarditis: from T cell imbalance to multicellular crosstalk.Front Immunol2026https://conductscience.org/library/papers/42327747PubMed
42279386Advances in Immune Checkpoint Inhibitors for Cancer Treatment.Cancers (Basel)2026https://conductscience.org/library/papers/42279386PubMed
42273361A homozygous CTLA-4 variant causes CTLA-4 deficiency with severe immune dysregulation.J Hum Immun2026https://conductscience.org/library/papers/42273361PubMed
42206056Unlocking the potential: current landscape and future directions of immunotherapy in gastric cancer.Front Immunol2026https://conductscience.org/library/papers/42206056PubMed
42162306Adaptive resistance in cancer immunotherapy.Cell Mol Immunol2026https://conductscience.org/library/papers/42162306PubMed
42158823Current Status and Evolution of Immunotherapy in Glioma Management.Int J Med Sci2026https://conductscience.org/library/papers/42158823PubMed
42064051Drug resistance mechanisms of immunotherapy and translational strategies for reversing resistance for hepatocellular carcinoma: from bench to bedside.Front Immunol2026https://conductscience.org/library/papers/42064051PubMed
41898300Targeting T-Cells for Cancer Treatment: Current Clinical Strategies and Challenges.Biomedicines2026https://conductscience.org/library/papers/41898300PubMed
41804110Synergizing Radiotherapy and Immune Checkpoint Inhibitors in Malignant Solid Tumours: Mechanistic Insights and Translational Frontiers.Expert Rev Mol Med2026https://conductscience.org/library/papers/41804110PubMed
41678466Influence of the tumor microenvironment on genetic mutations in thyroid carcinoma.PLoS One2026https://conductscience.org/library/papers/41678466PubMed
41613111The role of immune checkpoint molecules in cancers.Front Immunol2025https://conductscience.org/library/papers/41613111PubMed
41550427The Trojan Horse Within: Mechanisms of Immune Evasion in Breast Cancer.Cancer Heterog Plast2025https://conductscience.org/library/papers/41550427PubMed
41527444T Cell Exhaustion in Cancer Immunotherapy: Heterogeneity, Mechanisms, and Therapeutic Opportunities.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41527444PubMed

See all 521 cited byDownload CSV of cited by

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
GENBANKX05719

Source GENBANK

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3496540

GET https://conductscience.org/api/papers/v1/3496540/cited_by?page=2